<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Neurotransmitter receptors and postsynaptic signal transmission" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">The neurotransmitter in the synaptic cleft released by the pre-synaptic neuron binds specific receptors located on the post-synaptic terminal. These receptors are either ion channels or G protein coupled receptors that function to transmit the signals from the post-synaptic membrane to the cell body.
 View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=112314 Reactome].</Comment>
  <Comment Source="Reactome-Converter">Pathway is converted from Reactome ID: 112314</Comment>
  <Comment Source="Reactome-version">Reactome version: 88</Comment>
  <Comment Source="Reactome Author">Reactome Author: Mahajan, SS</Comment>
  <Attribute Key="reactome_id" Value="112314" />
  <Graphics BoardWidth="871.0" BoardHeight="1410.0" />
  <DataNode TextLabel="Ca2+" GraphId="b88db" Type="Metabolite">
    <Attribute Key="cellular_location" Value="extracellular region" />
    <Graphics CenterX="546.0" CenterY="85.0" Width="50.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="Ca2+" GraphId="bcae5" Type="Metabolite">
    <Attribute Key="cellular_location" Value="cytosol" />
    <Graphics CenterX="512.0" CenterY="292.0" Width="50.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29108" />
  </DataNode>
  <DataNode TextLabel="Na+" GraphId="a021f" Type="Metabolite">
    <Attribute Key="cellular_location" Value="cytosol" />
    <Graphics CenterX="390.5" CenterY="253.0" Width="43.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29101" />
  </DataNode>
  <DataNode TextLabel="Na+" GraphId="e25ef" Type="Metabolite">
    <Attribute Key="cellular_location" Value="extracellular region" />
    <Graphics CenterX="437.5" CenterY="84.0" Width="43.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29101" />
  </DataNode>
  <DataNode TextLabel="Cl-" GraphId="fbe26" Type="Metabolite">
    <Attribute Key="cellular_location" Value="extracellular region" />
    <Graphics CenterX="250.5" CenterY="107.0" Width="35.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:17996" />
  </DataNode>
  <DataNode TextLabel="Cl-" GraphId="e11dc" Type="Metabolite">
    <Attribute Key="cellular_location" Value="cytosol" />
    <Graphics CenterX="249.5" CenterY="229.0" Width="35.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:17996" />
  </DataNode>
  <DataNode TextLabel="GLRA:GLRB:Gly" GraphId="d4087" Type="Complex">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Graphics CenterX="170.0" CenterY="168.0" Width="84.0" Height="38.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="Hexagon" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-HSA-975385" />
  </DataNode>
  <DataNode TextLabel="GLRA1 " GraphId="ab584" Type="Protein" GroupRef="cc779">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-975385" />
    <Attribute Key="copies_num" Value="2" />
    <Graphics CenterX="100.0" CenterY="718.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P23415" />
  </DataNode>
  <DataNode TextLabel="GLRA2 " GraphId="cdd53" Type="Protein" GroupRef="cc779">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-975385" />
    <Attribute Key="copies_num" Value="3" />
    <Graphics CenterX="100.0" CenterY="738.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P23416" />
  </DataNode>
  <DataNode TextLabel="GLRA3 " GraphId="b2561" Type="Protein" GroupRef="cc779">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-975385" />
    <Attribute Key="copies_num" Value="4" />
    <Graphics CenterX="100.0" CenterY="758.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="O75311" />
  </DataNode>
  <DataNode TextLabel="GLRB " GraphId="d71a8" Type="Protein" GroupRef="cc779">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-975385" />
    <Attribute Key="copies_num" Value="6" />
    <Graphics CenterX="100.0" CenterY="778.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P48167" />
  </DataNode>
  <DataNode TextLabel="Gly " GraphId="da714" Type="Metabolite" GroupRef="cc779">
    <Attribute Key="cellular_location" Value="extracellular region" />
    <Attribute Key="complex_id" Value="R-HSA-975385" />
    <Attribute Key="copies_num" Value="6" />
    <Graphics CenterX="100.0" CenterY="798.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:57305" />
  </DataNode>
  <DataNode TextLabel="HTR3 pentamers:5HT" GraphId="d50ad" Type="Complex">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Graphics CenterX="367.0" CenterY="166.0" Width="102.0" Height="34.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="Hexagon" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-HSA-975348" />
  </DataNode>
  <DataNode TextLabel="5HT " GraphId="a2623" Type="Metabolite" GroupRef="fb91f">
    <Attribute Key="cellular_location" Value="extracellular region" />
    <Attribute Key="complex_id" Value="R-HSA-975348" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="858.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:350546" />
  </DataNode>
  <DataNode TextLabel="HTR3B " GraphId="b1c55" Type="Protein" GroupRef="fb91f">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-975348" />
    <Attribute Key="copies_num" Value="3" />
    <Graphics CenterX="100.0" CenterY="878.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="O95264" />
  </DataNode>
  <DataNode TextLabel="HTR3A " GraphId="bbac4" Type="Protein" GroupRef="fb91f">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-975348" />
    <Attribute Key="copies_num" Value="10" />
    <Graphics CenterX="100.0" CenterY="898.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P46098" />
  </DataNode>
  <DataNode TextLabel="HTR3C " GraphId="ddc05" Type="Protein" GroupRef="fb91f">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-975348" />
    <Attribute Key="copies_num" Value="12" />
    <Graphics CenterX="100.0" CenterY="918.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q8WXA8" />
  </DataNode>
  <DataNode TextLabel="HTR3D " GraphId="c7388" Type="Protein" GroupRef="fb91f">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-975348" />
    <Attribute Key="copies_num" Value="14" />
    <Graphics CenterX="100.0" CenterY="938.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q70Z44" />
  </DataNode>
  <DataNode TextLabel="HTR3E " GraphId="ab419" Type="Protein" GroupRef="fb91f">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-975348" />
    <Attribute Key="copies_num" Value="16" />
    <Graphics CenterX="100.0" CenterY="958.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="A5X5Y0" />
  </DataNode>
  <DataNode TextLabel="K+" GraphId="d3509" Type="Metabolite">
    <Attribute Key="cellular_location" Value="extracellular region" />
    <Graphics CenterX="484.5" CenterY="76.0" Width="35.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29103" />
  </DataNode>
  <DataNode TextLabel="K+" GraphId="a6577" Type="Metabolite">
    <Attribute Key="cellular_location" Value="cytosol" />
    <Graphics CenterX="452.5" CenterY="288.0" Width="35.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:29103" />
  </DataNode>
  <DataNode TextLabel="Acetylcholine&#xA;binding and&#xA;downstream events" GraphId="ae0c7" Type="Pathway">
    <Comment Source="Reactome">Acetylcholine is the neurotransmitter found at neuromuscular junctions, synapses in the ganglia of the visceral motor system, and at a variety of sites within the central nervous system. A great deal is known about the function of cholinergic transmission at the neuromuscular junction and at ganglionic synapses, the actions of ACh in the central nervous system are not as well understood. Acetylcholine is synthesized in nerve terminals from acetyl coenzyme A (acetyl CoA) synthesized from glucose) and choline. This reaction is catalyzed by choline acetyltransferase (ChAT). The presence of acetyltransferase in a neuron is thus a strong indication that ACh is used as one of its transmitters. Choline is present in plasma at a concentration of about 10 mM, and is taken up into cholinergic neurons by a high affinity Na+/choline transporter. About 10,000 molecules of ACh are packaged into each neurotransmitter containing vesicle by a vesicular ACh transporter.&lt;br&gt;

Nicotinic acetylcholine receptors (nAchR) are ionotropic receptors that can be activated by nicotine and permeable to of monovalent (sodium, potassium) and divalent cations(calcium), however, the permeability of sodium and/or calcium maybe high or low depending on the subunit composition of the receptor. Nicotinic acetylcholine receptors are expressed widely in the central and peripheral nervous system in the presynaptic terminal, terminal bouton and post synaptic neuron. Functionally nicotinic acetylcholine receptors in the pre synaptic and postsynaptic terminals behave similarly. Nicotinic AChR are a family of acetylcholine gated pentameric receptors that are formed by the association of various combinations of mostly alpha, beta subunits (for the neuronal type) and together with gamma, delta and epsilon subunits (for the muscle type). In addition, receptors may be more diverse due the fact that some receptors have same subunits but the stoichiometry of the subunits is different.</Comment>
    <BiopaxRef>b01</BiopaxRef>
    <BiopaxRef>aab</BiopaxRef>
    <BiopaxRef>e6f</BiopaxRef>
    <BiopaxRef>a24</BiopaxRef>
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="135.5" CenterY="364.0" Width="191.0" Height="66.0" ZOrder="32768" FontSize="10" Valign="Middle" LineThickness="0.0" Color="14961e" />
    <Xref Database="Reactome" ID="R-HSA-181431" />
  </DataNode>
  <DataNode TextLabel="Glutamate binding,&#xA;activation of AMPA&#xA;receptors and&#xA;synaptic plasticity" GraphId="ad0bd" Type="Pathway">
    <Comment Source="Reactome">Excitatory synaptic transmission in the brain is carried out by glutamate receptors through the activation of both ionotropic and metabotropic receptors.  Ionotropic glutamate receptors are of three subtypes based on distinct physiologic properties and their differential binding of exogenous ligands namely  NMDA (N-methyl D-aspartate), AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) and Kainate . The ionotropic receptors are glutamate gated ion channels that initiate signaling by influx of ions, and are comprised of subunits with distinct structures and distinguished based on their agonist binding. Even though all three types of receptors are found at the glutamatergic synapses yet they exhibit great diversity in the synaptic distribution. The metabotropic glutamate receptors are a family of G-protein coupled receptors that are slow acting.  Fast excitatory synaptic transmission is carried out through AMPA receptors. Post-synaptic transmission involves binding of the ligand such as glutamate/AMPA to the AMPA receptor resulting in the Na influx which causes depolarization of the membrane. NMDA receptors are blocked by Mg at resting membrane potential. NMDA receptors are activated upon coincident depolarization and glutamate binding are activated following AMPA receptor activation.NMDA receptors are blocked by Mg at resting &lt;br&gt;membrane potential. NMDA receptors are Ca permeable and their activity leads to increase in Ca which, leads to upregulation of AMPA receptors at the synapse which causes the long lasting excitatory post-synaptic potential (EPSP) which forms the basis of long term potentiation (LTP). LTP is one form of synaptic plasticity wherein the strength of the synapses is enhanced by either change in the number, increase in the efficacy by phosphorylation or change in the type of receptors. Phosphorylation of AMPA receptors changes the localization of the receptors, increases the single channel conductance, and increases the probability of open channel. GluR1 has four phosphorylation sites; serine 818 (S818) is phosphorylated by PKC and is necessary for LTP, serine 831 (S831) is phosphorylated by CaMKII  that increases the delivery of receptors to the synapse and also increased their single channel conductance, threonine (T840) is implicated in LTP. Serine 845 (S845) is phosphorylated by PKA which regulates open channel probability.  Long term depression is another form of plasticity wherein the number of AMPA receptors is diminished by either phosphorylation of GluR2 at Ser880 or dephosphorylation of GluR1 by protein phosphatase1, protein phosphatase 2A and protein phosphatase 2B (calcineurin).</Comment>
    <BiopaxRef>af8</BiopaxRef>
    <BiopaxRef>a28</BiopaxRef>
    <BiopaxRef>b20</BiopaxRef>
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="134.0" CenterY="441.5" Width="198.0" Height="73.0" ZOrder="32768" FontSize="10" Valign="Middle" LineThickness="0.0" Color="14961e" />
    <Xref Database="Reactome" ID="R-HSA-399721" />
  </DataNode>
  <DataNode TextLabel="Activation of NMDA&#xA;receptors and&#xA;postsynaptic events" GraphId="a6b4e" Type="Pathway">
    <Comment Source="Reactome">NMDA receptors are a subtype of ionotropic glutamate receptors that are specifically activated by a glutamate agonist N-methyl-D-aspartate (NMDA). Activation of NMDA receptors involves opening of the ion channel that allows the influx of Ca2+. NMDA receptors are central to activity dependent changes in synaptic strength and are predominantly involved in the synaptic plasticity that pertains to learning and memory. A unique feature of NMDA receptors, unlike other glutamate receptors, is the requirement for dual activation, both voltage-dependent and ligand-dependent activation. The ligand-dependent activation of NMDA receptors requires co-activation by two ligands, glutamate and glycine. However, at resting membrane potential, the pore of ligand-bound NMDA receptors is blocked by Mg2+. The voltage dependent Mg2+ block is relieved upon depolarization of the post-synaptic membrane. NMDA receptors are coincidence detectors, and are activated only if there is a simultaneous activation of both pre- and post-synaptic cell. Upon activation, NMDA receptors allow the influx of Ca2+ that initiates various molecular signaling cascades involved in the processes of learning and memory. For review, please refer to Cohen and Greenberg 2008, Hardingham and Bading 2010, Traynelis et al. 2010, and Paoletti et al. 2013.</Comment>
    <BiopaxRef>fb1</BiopaxRef>
    <BiopaxRef>f3a</BiopaxRef>
    <BiopaxRef>feb</BiopaxRef>
    <BiopaxRef>e6c</BiopaxRef>
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="135.5" CenterY="519.0" Width="197.0" Height="60.0" ZOrder="32768" FontSize="10" Valign="Middle" LineThickness="0.0" Color="14961e" />
    <Xref Database="Reactome" ID="R-HSA-442755" />
  </DataNode>
  <DataNode TextLabel="Activation of&#xA;kainate receptors&#xA;upon glutamate&#xA;binding" GraphId="d3618" Type="Pathway">
    <Comment Source="Reactome">Kainate receptors are found both in the presynaptc terminals and the postsynaptic neurons.  &lt;br&gt;Kainate receptor activation could lead to either ionotropic activity (influx of Ca2+ or Na+ and K+) in the postsynaptic neuron or coupling of the receptor with G proteins in the presynaptic and the postsynaptic neurons. &lt;br&gt;Kainate receptors are tetramers made from subunits GRIK1-5 or GluR5-7 and KA1-2. Activation of kainate receptors made from GRIK1 or KA2 release Ca2+ from the intracellular stores in a G protein-dependent manner. The G protein involved in this process is sensitive to pertussis toxin.</Comment>
    <BiopaxRef>e9f</BiopaxRef>
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="137.5" CenterY="593.0" Width="159.0" Height="70.0" ZOrder="32768" FontSize="10" Valign="Middle" LineThickness="0.0" Color="14961e" />
    <Xref Database="Reactome" ID="R-HSA-451326" />
  </DataNode>
  <DataNode TextLabel="GABA receptor&#xA;activation" GraphId="aab81" Type="Pathway">
    <Comment Source="Reactome">Gamma aminobutyric acid (GABA) receptors are the major inhibitory receptors in human synapses. They are of two types. GABA A receptors are fast-acting ligand gated chloride ion channels that mediate membrane depolarization and thus inhibit neurotransmitter release (G Michels et al Crit Rev Biochem Mol Biol 42, 2007, 3-14). GABA B receptors are slow acting metabotropic Gprotein coupled receptors that act via the inhibitory action of their Galpha/Go subunits on adenylate cyclase to attenuate the actions of PKA. In addition, their Gbeta/gamma subunits interact directly with N and P/Q Ca2+ channels to decrease the release of Ca2+. GABA B receptors also interact with Kir3 K+ channels and increase the influx of K+, leading to cell membrane hyperpolarization and inhibition of channels such as NMDA receptors (A Pinard et al Adv Pharmacol, 58, 2010, 231-55).
</Comment>
    <BiopaxRef>c13</BiopaxRef>
    <BiopaxRef>eaa</BiopaxRef>
    <BiopaxRef>df3</BiopaxRef>
    <BiopaxRef>ce0</BiopaxRef>
    <BiopaxRef>cec</BiopaxRef>
    <Attribute Key="org.pathvisio.DoubleLineProperty" Value="Double" />
    <Graphics CenterX="139.5" CenterY="663.0" Width="147.0" Height="54.0" ZOrder="32768" FontSize="10" Valign="Middle" LineThickness="0.0" Color="14961e" />
    <Xref Database="Reactome" ID="R-HSA-977443" />
  </DataNode>
  <DataNode TextLabel="HTR3A pentamer:5HT" GraphId="cb2c5" Type="Complex">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Graphics CenterX="595.0" CenterY="168.0" Width="104.0" Height="36.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="Hexagon" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-HSA-6792757" />
  </DataNode>
  <DataNode TextLabel="HTR3A " GraphId="a9605" Type="Protein" GroupRef="a1093">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-6792757" />
    <Attribute Key="copies_num" Value="5" />
    <Graphics CenterX="100.0" CenterY="1018.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P46098" />
  </DataNode>
  <DataNode TextLabel="5HT " GraphId="c999f" Type="Metabolite" GroupRef="a1093">
    <Attribute Key="cellular_location" Value="extracellular region" />
    <Attribute Key="complex_id" Value="R-HSA-6792757" />
    <Attribute Key="copies_num" Value="5" />
    <Graphics CenterX="100.0" CenterY="1038.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:350546" />
  </DataNode>
  <DataNode TextLabel="HTR3A antagonists" GraphId="bcd5e" Type="Complex">
    <Attribute Key="cellular_location" Value="cytosol" />
    <Graphics CenterX="785.0" CenterY="288.5" Width="112.0" Height="35.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="RoundedRectangle" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-ALL-9648956" />
  </DataNode>
  <DataNode TextLabel="ondansetron " GraphId="e72fa" GroupRef="c4135">
    <Attribute Key="cellular_location" Value="cytosol" />
    <Attribute Key="complex_id" Value="R-ALL-9648956" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="0.0" CenterY="0.0" Width="0.0" Height="0.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="" ID="" />
  </DataNode>
  <DataNode TextLabel="HTR3A pentamer:HTR3A&#xA;antagonists" GraphId="e1be6" Type="Complex">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Graphics CenterX="685.5" CenterY="364.0" Width="117.0" Height="48.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="Hexagon" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-HSA-9648959" />
  </DataNode>
  <DataNode TextLabel="ondansetron " GraphId="df43b" GroupRef="fe58f">
    <Attribute Key="cellular_location" Value="cytosol" />
    <Attribute Key="complex_id" Value="R-HSA-9648959" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="0.0" CenterY="0.0" Width="0.0" Height="0.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="" ID="" />
  </DataNode>
  <DataNode TextLabel="5HT" GraphId="f3845" Type="Metabolite">
    <Attribute Key="cellular_location" Value="extracellular region" />
    <Graphics CenterX="741.0" CenterY="132.0" Width="40.0" Height="30.0" ZOrder="32768" FontSize="10" Valign="Middle" Color="0000ff" />
    <Xref Database="ChEBI" ID="CHEBI:350546" />
  </DataNode>
  <DataNode TextLabel="HTR3A pentamer" GraphId="d6abd" Type="Complex">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Graphics CenterX="686.5" CenterY="235.5" Width="67.0" Height="35.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="Hexagon" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-HSA-9649110" />
  </DataNode>
  <DataNode TextLabel="HTR3A " GraphId="bdb8c" Type="Protein" GroupRef="af4e2">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-9649110" />
    <Attribute Key="copies_num" Value="5" />
    <Graphics CenterX="100.0" CenterY="1098.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P46098" />
  </DataNode>
  <DataNode TextLabel="NBEA" GraphId="a21ec" Type="Protein">
    <Attribute Key="cellular_location" Value="cytosol" />
    <Graphics CenterX="231.0" CenterY="291.5" Width="46.0" Height="23.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q8NFP9" />
  </DataNode>
  <DataNode TextLabel="GLRA:GLRB&#xA;heteropentamer:NBEA" GraphId="d87fa" Type="Complex">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Graphics CenterX="94.5" CenterY="226.0" Width="107.0" Height="52.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="Hexagon" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-HSA-9673178" />
  </DataNode>
  <DataNode TextLabel="NBEA " GraphId="e6adc" Type="Protein" GroupRef="e3fbc">
    <Attribute Key="cellular_location" Value="cytosol" />
    <Attribute Key="complex_id" Value="R-HSA-9673178" />
    <Attribute Key="copies_num" Value="1" />
    <Graphics CenterX="100.0" CenterY="1158.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="Q8NFP9" />
  </DataNode>
  <DataNode TextLabel="GLRA1 " GraphId="bb338" Type="Protein" GroupRef="e3fbc">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-9673178" />
    <Attribute Key="copies_num" Value="2" />
    <Graphics CenterX="100.0" CenterY="1178.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P23415" />
  </DataNode>
  <DataNode TextLabel="GLRA2 " GraphId="c6aa1" Type="Protein" GroupRef="e3fbc">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-9673178" />
    <Attribute Key="copies_num" Value="3" />
    <Graphics CenterX="100.0" CenterY="1198.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P23416" />
  </DataNode>
  <DataNode TextLabel="GLRA3 " GraphId="a964e" Type="Protein" GroupRef="e3fbc">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-9673178" />
    <Attribute Key="copies_num" Value="4" />
    <Graphics CenterX="100.0" CenterY="1218.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="O75311" />
  </DataNode>
  <DataNode TextLabel="GLRB " GraphId="d2030" Type="Protein" GroupRef="e3fbc">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-9673178" />
    <Attribute Key="copies_num" Value="6" />
    <Graphics CenterX="100.0" CenterY="1238.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P48167" />
  </DataNode>
  <DataNode TextLabel="GLRA:GLRB&#xA;heteropentamer" GraphId="cd28a" Type="Complex">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Graphics CenterX="111.0" CenterY="299.0" Width="102.0" Height="36.0" ZOrder="32768" FontSize="10" Valign="Middle" ShapeType="Hexagon" Color="a52a2a" />
    <Xref Database="Reactome" ID="R-HSA-9676814" />
  </DataNode>
  <DataNode TextLabel="GLRA1 " GraphId="a814b" Type="Protein" GroupRef="a980b">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-9676814" />
    <Attribute Key="copies_num" Value="2" />
    <Graphics CenterX="100.0" CenterY="1298.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P23415" />
  </DataNode>
  <DataNode TextLabel="GLRA2 " GraphId="d549c" Type="Protein" GroupRef="a980b">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-9676814" />
    <Attribute Key="copies_num" Value="3" />
    <Graphics CenterX="100.0" CenterY="1318.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P23416" />
  </DataNode>
  <DataNode TextLabel="GLRA3 " GraphId="a621a" Type="Protein" GroupRef="a980b">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-9676814" />
    <Attribute Key="copies_num" Value="4" />
    <Graphics CenterX="100.0" CenterY="1338.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="O75311" />
  </DataNode>
  <DataNode TextLabel="GLRB " GraphId="c6921" Type="Protein" GroupRef="a980b">
    <Attribute Key="cellular_location" Value="plasma membrane" />
    <Attribute Key="complex_id" Value="R-HSA-9676814" />
    <Attribute Key="copies_num" Value="6" />
    <Graphics CenterX="100.0" CenterY="1358.0" Width="100.0" Height="20.0" ZOrder="32768" FontSize="10" Valign="Middle" />
    <Xref Database="Uniprot-TrEMBL" ID="P48167" />
  </DataNode>
  <Interaction GraphId="c98cb">
    <Comment Source="Reactome">The glycine receptor (GLR) is a ligand-gated ion channel. It is functional as a heteropentamer, consisting of alpha (GLRA) and beta (GLRB) subunits. With no ligand bound, the receptor complex is closed to chloride ions. Binding of the inhibitory neurotransmitter glycine (Gly) to this receptor complex increases chloride conductance into neurons and thus produces hyperpolarization (inhibition of neuronal firing) (Grenningloh et al. 1990, Nikolic et al. 1998, Handford et al. 1996).</Comment>
    <BiopaxRef>bd8</BiopaxRef>
    <BiopaxRef>b0c</BiopaxRef>
    <BiopaxRef>de3</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="249.0" Y="125.0" />
      <Point X="249.0" Y="211.0" />
      <Anchor Position="0.0" Shape="None" GraphId="ec28e" />
      <Anchor Position="0.99" Shape="None" GraphId="d5df3" />
      <Anchor Position="0.5" Shape="None" GraphId="f9450" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-975389" />
  </Interaction>
  <Interaction GraphId="b6b23">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="250.0" Y="122.0" GraphRef="fbe26" RelX="-0.02857142857142857" RelY="1.0" />
      <Point X="249.0" Y="125.0" GraphRef="ec28e" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-975389" />
  </Interaction>
  <Interaction GraphId="aea28">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="249.0" Y="211.0" GraphRef="d5df3" RelX="0.0" RelY="0.8600000000000136" />
      <Point X="249.0" Y="214.0" GraphRef="e11dc" RelX="-0.02857142857142857" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-975389" />
  </Interaction>
  <Interaction GraphId="a2069">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="212.0" Y="168.0" GraphRef="d4087" RelX="1.0" RelY="0.0" />
      <Point X="249.0" Y="169.0" GraphRef="f9450" RelX="0.0" RelY="1.0" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-975389" />
  </Interaction>
  <Interaction GraphId="c5201">
    <Comment Source="Reactome">The 5-hydroxytryptamine receptor (HTR3) family are members of the superfamily of ligand-gated ion channels (LGICs). Five receptors (HTR3A-E) can form a homopentamer (HTR3A) or heteropentamers (HTR3A with B, C, D or E) (Barrera et al. 2005, Niesler et al. 2007; reviews - Barnes et al. 2009, Wu et al. 2015) Although heterpentamer composition can vary between the two receptors binding, the example 2xHTR3A:3xHTR3(B-E) is shown here. Binding of the neurotransmitter 5-hydroxytryptamine (5HT, serotonin) to the HTR3 complex opens the channel, which in turn, leads to an excitatory response in neurons and is permeable to sodium, potassium, and calcium ions (Miyake et al. 1995, Davies et al. 1999).</Comment>
    <BiopaxRef>ff0</BiopaxRef>
    <BiopaxRef>a16</BiopaxRef>
    <BiopaxRef>e47</BiopaxRef>
    <BiopaxRef>e0e</BiopaxRef>
    <BiopaxRef>b69</BiopaxRef>
    <BiopaxRef>de9</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="468.0" Y="132.0" />
      <Point X="468.0" Y="199.0" />
      <Anchor Position="0.0" Shape="None" GraphId="c76a7" />
      <Anchor Position="0.99" Shape="None" GraphId="e2f70" />
      <Anchor Position="0.5" Shape="None" GraphId="a67ac" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-975311" />
  </Interaction>
  <Interaction GraphId="f7b1f">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="484.0" Y="91.0" GraphRef="d3509" RelX="-0.02857142857142857" RelY="1.0" />
      <Point X="468.0" Y="132.0" GraphRef="c76a7" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-975311" />
  </Interaction>
  <Interaction GraphId="fba0b">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="521.0" Y="85.0" GraphRef="b88db" RelX="-1.0" RelY="0.0" />
      <Point X="468.0" Y="132.0" GraphRef="c76a7" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-975311" />
  </Interaction>
  <Interaction GraphId="d775a">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="437.0" Y="99.0" GraphRef="e25ef" RelX="-0.023255813953488372" RelY="1.0" />
      <Point X="468.0" Y="132.0" GraphRef="c76a7" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-975311" />
  </Interaction>
  <Interaction GraphId="fbd65">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="468.0" Y="199.0" GraphRef="e2f70" RelX="0.0" RelY="0.6700000000000159" />
      <Point X="452.0" Y="273.0" GraphRef="a6577" RelX="-0.02857142857142857" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-975311" />
  </Interaction>
  <Interaction GraphId="a4812">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="468.0" Y="199.0" GraphRef="e2f70" RelX="0.0" RelY="0.6700000000000159" />
      <Point X="512.0" Y="277.0" GraphRef="bcae5" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-975311" />
  </Interaction>
  <Interaction GraphId="eaf1b">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="468.0" Y="199.0" GraphRef="e2f70" RelX="0.0" RelY="0.6700000000000159" />
      <Point X="411.0" Y="253.0" GraphRef="a021f" RelX="0.9534883720930233" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-975311" />
  </Interaction>
  <Interaction GraphId="a291c">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="418.0" Y="166.0" GraphRef="d50ad" RelX="1.0" RelY="0.0" />
      <Point X="468.0" Y="168.0" GraphRef="a67ac" RelX="0.0" RelY="2.5" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-975311" />
  </Interaction>
  <Interaction GraphId="eb376">
    <Comment Source="Reactome">The 5-hydroxytryptamine receptor (HTR3) family are members of the superfamily of ligand-gated ion channels (LGICs). Five receptors (HTR3A-E) can form a homopentamer (HTR3A) or heteropentamers (HTR3A with B, C, D or E) (Barrera et al. 2005, Niesler et al. 2007; reviews - Barnes et al. 2009, Wu et al. 2015). Binding of the neurotransmitter 5-hydroxytryptamine (5HT, serotonin) to the HTR3 pentamer opens the channel making it permeable to sodium, potassium, and calcium ions, which in turn leads to an excitatory response in neurons (Miyake et al. 1995, Davies et al. 1999).</Comment>
    <BiopaxRef>ff0</BiopaxRef>
    <BiopaxRef>a16</BiopaxRef>
    <BiopaxRef>e47</BiopaxRef>
    <BiopaxRef>e0e</BiopaxRef>
    <BiopaxRef>b69</BiopaxRef>
    <BiopaxRef>de9</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="490.0" Y="115.0" />
      <Point X="490.0" Y="220.0" />
      <Anchor Position="0.0" Shape="None" GraphId="c36b2" />
      <Anchor Position="0.99" Shape="None" GraphId="cf7ad" />
      <Anchor Position="0.5" Shape="None" GraphId="c8490" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9648983" />
  </Interaction>
  <Interaction GraphId="edf71">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="521.0" Y="85.0" GraphRef="b88db" RelX="-1.0" RelY="0.0" />
      <Point X="490.0" Y="115.0" GraphRef="c36b2" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9648983" />
  </Interaction>
  <Interaction GraphId="c2235">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="458.0" Y="84.0" GraphRef="e25ef" RelX="0.9534883720930233" RelY="0.0" />
      <Point X="490.0" Y="115.0" GraphRef="c36b2" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9648983" />
  </Interaction>
  <Interaction GraphId="e8268">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="484.0" Y="91.0" GraphRef="d3509" RelX="-0.02857142857142857" RelY="1.0" />
      <Point X="490.0" Y="115.0" GraphRef="c36b2" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9648983" />
  </Interaction>
  <Interaction GraphId="e998f">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="490.0" Y="220.0" GraphRef="cf7ad" RelX="0.0" RelY="1.0500000000000114" />
      <Point X="512.0" Y="277.0" GraphRef="bcae5" RelX="0.0" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9648983" />
  </Interaction>
  <Interaction GraphId="fbb85">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="490.0" Y="220.0" GraphRef="cf7ad" RelX="0.0" RelY="1.0500000000000114" />
      <Point X="452.0" Y="273.0" GraphRef="a6577" RelX="-0.02857142857142857" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9648983" />
  </Interaction>
  <Interaction GraphId="b8a28">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="490.0" Y="220.0" GraphRef="cf7ad" RelX="0.0" RelY="1.0500000000000114" />
      <Point X="411.0" Y="253.0" GraphRef="a021f" RelX="0.9534883720930233" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9648983" />
  </Interaction>
  <Interaction GraphId="b02d8">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="543.0" Y="168.0" GraphRef="cb2c5" RelX="-1.0" RelY="0.0" />
      <Point X="490.0" Y="168.0" GraphRef="c8490" RelX="0.0" RelY="0.5" ArrowHead="mim-catalysis" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9648983" />
  </Interaction>
  <Interaction GraphId="da0e7">
    <Comment Source="Reactome">5-hydroxytryptamine receptors 3A (HTR3As, 5-HT3) are present in several critical sites in the CNS involved in emesis and are involved in the integration of the vomiting reflex, pain processing, anxiety control and the reward system. Serotonin (5HT) is released by enterochromaffin cells of the small intestine in response to chemotherapeutic agents which may stimulate vagal afferents (via HTR3A receptors) to initiate the vomiting reflex. 5-HT3 antagonist drugs suppress vomiting and nausea by inhibiting serotonin binding to HTR3A receptors (Tyers &amp; Freeman 1992). 5-HT3 antagonists are widely used for relieving chemotherapy-induced vomiting (Gilmore et al. 2018) as well as radiotherapy-induced and post-operative nausea and vomiting.&lt;br&gt;&lt;br&gt;5-HT3 antagonists are informally known as "setrons" and are a class of drugs that act as receptor antagonists at the HTR3A receptor. With the  exceptions of alosetron and cilansetron, which are used in the treatment of irritable bowel syndrome, all 5-HT3 antagonists are antiemetics, used in the prevention and treatment of nausea and vomiting. 5-HT3 antagonists, although sharing the same mechanism of action, have different chemical structures which lends itself to different affinities for the receptor, dose response, duration of action and different metabolic routes via the cytochrome P450 system. Due to these differences, patients resistant to one antagonist may respond well to another (Gan 2005).&lt;br&gt;&lt;br&gt;Ondansetron (brand name Zofran) was the first 5-HT3 antagonist, developed by Glaxo in 1984 and approved by the U.S. FDA in 1991 (Griddine &amp; Bush 2019). It is also available in several other countries, including the UK, Ireland, Australia, Canada, France and Brazil. Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, or surgery (Markham &amp; Sorkin 1993) and is also useful in gastroenteritis therapy (Schnadower et al. 2015). Granisetron (trade name Kytril) is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy. The drug was approved in the United Kingdom in 1991 and in the United States in 1994. Granisetron is metabolized slowly by the liver, giving it a longer than average half-life (Hsu 2010).&lt;br&gt;&lt;br&gt;Approved in 2003 by the FDA, palonosetron (trade name Aloxi) is a second generation 5-HT3 receptor antagonist. Unlike the first generation 5-HT3 receptor antagonists, palonosetron demonstrates efficacy in preventing both acute and delayed emesis (Navari 2014). Tropisetron (trade name Navoban) is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic to treat nausea and vomiting following chemotherapy (Lee et al. 1993). It was approved for medical use in 1992 in Europe, Australia, New Zealand, Japan, South Korea and the Philippines but is not available in the U.S.&lt;br&gt;&lt;br&gt;Ramosetron is a serotonin 5-HT3 receptor antagonist for the treatment of nausea and vomiting (Rabasseda 2002) and for a treatment of diarrhea-predominant irritable bowel syndrome (Hirata et al. 2007, Min &amp; Rhee 2015). It is only licensed for use in Japan and selected Southeast Asian countries and in India. Alosetron (brand name Lotronex) has an antagonist action on the 5-HT3 receptors of the enteric nervous system of the GI tract. It is not classified or approved as an antiemetic, instead, it is used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only (Lacy et al. 2018). It was withdrawn from the market in 2000 due to serious life-threatening gastrointestinal adverse effects (Camilleri  et al. 2001), but was reintroduced in 2002 with restricted availability and use (Lucak 2010).&lt;br&gt;&lt;br&gt;Cilansetron is the first 5-HT3 antagonist specifically designed for IBS that is effective in men as well as women (Olden &amp; Crowell 2005, Zheng et al. 2017). The drug is not available in the U.S. but the manufacturer, Solvay, is in discussion with the MHRA (UK) and EU regulators. Azasetron is an antiemetic which acts as a 5-HT3 receptor antagonist used in the management of nausea and vomiting induced by cancer chemotherapy (Endo et al. 2012). It is approved for marketing in Japan under the trade name Serotone.</Comment>
    <BiopaxRef>f5a</BiopaxRef>
    <BiopaxRef>f47</BiopaxRef>
    <BiopaxRef>a05</BiopaxRef>
    <BiopaxRef>bed</BiopaxRef>
    <BiopaxRef>de8</BiopaxRef>
    <BiopaxRef>f62</BiopaxRef>
    <BiopaxRef>f1e</BiopaxRef>
    <BiopaxRef>fa5</BiopaxRef>
    <BiopaxRef>ac9</BiopaxRef>
    <BiopaxRef>c83</BiopaxRef>
    <BiopaxRef>d37</BiopaxRef>
    <BiopaxRef>a2b</BiopaxRef>
    <BiopaxRef>b1c</BiopaxRef>
    <BiopaxRef>e32</BiopaxRef>
    <BiopaxRef>de7</BiopaxRef>
    <BiopaxRef>cba</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="685.0" Y="287.0" />
      <Point X="685.0" Y="337.0" />
      <Anchor Position="0.0" Shape="None" GraphId="a986a" />
      <Anchor Position="0.99" Shape="None" GraphId="d91bd" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9648949" />
  </Interaction>
  <Interaction GraphId="e08db">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="729.0" Y="288.0" GraphRef="bcd5e" RelX="-1.0" RelY="-0.02857142857142857" />
      <Point X="685.0" Y="287.0" GraphRef="a986a" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9648949" />
  </Interaction>
  <Interaction GraphId="b4f25">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="686.0" Y="252.0" GraphRef="d6abd" RelX="-0.014925373134328358" RelY="0.9428571428571428" />
      <Point X="685.0" Y="287.0" GraphRef="a986a" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9648949" />
  </Interaction>
  <Interaction GraphId="dc744">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="685.0" Y="337.0" GraphRef="d91bd" RelX="0.0" RelY="0.5" />
      <Point X="685.0" Y="340.0" GraphRef="e1be6" RelX="-0.008547008547008548" RelY="-1.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9648949" />
  </Interaction>
  <Interaction GraphId="bd5b9">
    <Comment Source="Reactome">The 5-hydroxytryptamine receptor (HTR3) family are members of the superfamily of ligand-gated ion channels (LGICs). Five receptors (HTR3A-E) can form a homopentamer (HTR3A) or heteropentamers (HTR3A with B, C, D or E) (Barrera et al. 2005, Niesler et al. 2007; reviews - Barnes et al. 2009, Wu et al. 2015). Binding of the neurotransmitter 5-hydroxytryptamine (5HT, serotonin) to the HTR3 pentamer opens the channel making it permeable to sodium, potassium, and calcium ions, which in turn leads to an excitatory response in neurons (Miyake et al. 1995, Davies et al. 1999).</Comment>
    <BiopaxRef>ff0</BiopaxRef>
    <BiopaxRef>a16</BiopaxRef>
    <BiopaxRef>e47</BiopaxRef>
    <BiopaxRef>e0e</BiopaxRef>
    <BiopaxRef>b69</BiopaxRef>
    <BiopaxRef>de9</BiopaxRef>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="685.0" Y="168.0" />
      <Point X="650.0" Y="167.0" />
      <Anchor Position="0.0" Shape="None" GraphId="a444a" />
      <Anchor Position="0.99" Shape="None" GraphId="a2d61" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9649108" />
  </Interaction>
  <Interaction GraphId="f1e0c">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="721.0" Y="132.0" GraphRef="f3845" RelX="-1.0" RelY="0.0" />
      <Point X="685.0" Y="168.0" GraphRef="a444a" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9649108" />
  </Interaction>
  <Interaction GraphId="a8147">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="686.0" Y="218.0" GraphRef="d6abd" RelX="-0.014925373134328358" RelY="-1.0" />
      <Point X="685.0" Y="168.0" GraphRef="a444a" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9649108" />
  </Interaction>
  <Interaction GraphId="e06d8">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="650.0" Y="167.0" GraphRef="a2d61" RelX="-0.35000000000002274" RelY="-0.009999999999990905" />
      <Point X="647.0" Y="168.0" GraphRef="cb2c5" RelX="1.0" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9649108" />
  </Interaction>
  <Interaction GraphId="cbeb6">
    <Comment Source="Reactome">Binding of NBEA to GLRB (glycine receptor beta subunit) was demonstrated by co-immunoprecipitation of recombinant rat Glrb with endogenous Nbea from rat brain, as well as co-immunoprecipitation of recombinant rat Glrb with recombinant mouse Nbea. It was also shown, by immunocytochemistry, that NBEA and glycine receptor co-localize at postsynaptic densities of inhibitory synapses (del Pino et al. 2011). NBEA may be involved in trafficking of glycine receptors to the plasma membrane. As glycine receptors are pre-assembled at the endoplasmic reticulum (Griffon et al. 1999), the reaction diagram depicts binding of NBEA to this pre-assembled receptor complex, consisting of glycine receptor alpha and beta subunits. </Comment>
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="202.0" Y="253.0" />
      <Point X="151.0" Y="222.0" />
      <Anchor Position="0.0" Shape="None" GraphId="e9889" />
      <Anchor Position="0.99" Shape="None" GraphId="aa9a1" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9673173" />
  </Interaction>
  <Interaction GraphId="c52b3">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="208.0" Y="291.0" GraphRef="a21ec" RelX="-1.0" RelY="-0.043478260869565216" />
      <Point X="202.0" Y="253.0" GraphRef="e9889" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9673173" />
  </Interaction>
  <Interaction GraphId="c90ff">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="162.0" Y="299.0" GraphRef="cd28a" RelX="1.0" RelY="0.0" />
      <Point X="202.0" Y="253.0" GraphRef="e9889" RelX="0.0" RelY="0.0" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9673173" />
  </Interaction>
  <Interaction GraphId="dcc1c">
    <Graphics ConnectorType="Segmented" ZOrder="12288" LineThickness="1.0">
      <Point X="151.0" Y="222.0" GraphRef="aa9a1" RelX="-0.5099999999999909" RelY="-0.3100000000000023" />
      <Point X="147.0" Y="226.0" GraphRef="d87fa" RelX="0.9813084112149533" RelY="0.0" ArrowHead="Arrow" />
    </Graphics>
    <Xref Database="Reactome" ID="R-HSA-9673173" />
  </Interaction>
  <Label TextLabel="cytosol" GraphId="e386c" GroupRef="af9cf">
    <Graphics CenterX="297.0" CenterY="309.5" Width="64.0" Height="33.0" ZOrder="28672" FillColor="ffffff" FontSize="10" Valign="Middle" />
  </Label>
  <Shape GraphId="b5dd0" GroupRef="af9cf">
    <Graphics CenterX="408.0" CenterY="421.5" Width="562.0" Height="515.0" ZOrder="16384" FontSize="10" Valign="Middle" ShapeType="RoundedRectangle" LineThickness="3.0" Color="c0c0c0" Rotation="0.0" />
  </Shape>
  <Group GroupId="cc779" GraphId="ca0ed" Style="Complex">
    <Attribute Key="complex_id" Value="R-HSA-975385" />
  </Group>
  <Group GroupId="fb91f" GraphId="c9b8b" Style="Complex">
    <Attribute Key="complex_id" Value="R-HSA-975348" />
  </Group>
  <Group GroupId="a1093" GraphId="c5880" Style="Complex">
    <Attribute Key="complex_id" Value="R-HSA-6792757" />
  </Group>
  <Group GroupId="c4135" GraphId="a24f3">
    <Attribute Key="complex_id" Value="R-ALL-9648956" />
  </Group>
  <Group GroupId="fe58f" GraphId="cfae9" Style="Complex">
    <Attribute Key="complex_id" Value="R-HSA-9648959" />
  </Group>
  <Group GroupId="af4e2" GraphId="aa31c" Style="Complex">
    <Attribute Key="complex_id" Value="R-HSA-9649110" />
  </Group>
  <Group GroupId="e3fbc" GraphId="be2d9" Style="Complex">
    <Attribute Key="complex_id" Value="R-HSA-9673178" />
  </Group>
  <Group GroupId="a980b" GraphId="aba3b" Style="Complex">
    <Attribute Key="complex_id" Value="R-HSA-9676814" />
  </Group>
  <Group GroupId="af9cf" GraphId="a6e8a" Style="Group" />
  <InfoBox CenterX="0.0" CenterY="0.0" />
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b01">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11532443</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neuronal nicotinic receptors: from protein structure to function.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Itier V, Bertrand D.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aab">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">19481063</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Structural and functional diversity of native brain neuronal nicotinic receptors.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gotti C, Clementi F, Fornari A, Gaimarri A, Guiducci S, Manfredi I, Moretti M, Pedrazzi P, Pucci L, Zoli M.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e6f">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">19126755</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mammalian nicotinic acetylcholine receptors: from structure to function.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Albuquerque EX, Pereira EF, Alkondon M, Rogers SW.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a24">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18691557</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neuronal nicotinic acetylcholine receptors: from the genetic analysis to neurological diseases.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Steinlein OK, Bertrand D.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="af8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">16713244</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Regulation of Ca2+-permeable AMPA receptors: synaptic plasticity and beyond.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cull-Candy S, Kelly L, Farrant M.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a28">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">19217372</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Synaptic AMPA receptor plasticity and behavior.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kessels HW, Malinow R.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b20">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">16904750</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Synaptic plasticity and phosphorylation.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lee HK.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb1">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18616423</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Communication between the synapse and the nucleus in neuronal development, plasticity, and disease.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cohen S, Greenberg ME.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f3a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20842175</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hardingham GE, Bading H.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="feb">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">23686171</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Paoletti P, Bellone C, Zhou Q.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e6c">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20716669</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Glutamate receptor ion channels: structure, regulation, and function.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e9f">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18793656</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kainate receptors: pharmacology, function and therapeutic potential.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jane DE, Lodge D, Collingridge GL.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c13">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20655485</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GABAB receptors: physiological functions and mechanisms of diversity.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pinard A, Seddik R, Bettler B.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eaa">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20655481</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GABAB receptor coupling to G-proteins and ion channels.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Padgett CL, Slesinger PA.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="df3">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15269338</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular structure and physiological functions of GABA(B) receptors.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bettler B, Kaupmann K, Mosbacher J, Gassmann M.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ce0">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17364682</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GABAA receptors: properties and trafficking.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Michels G, Moss SJ.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cec">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11283747</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Constructing inhibitory synapses.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moss SJ, Smart TG.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bd8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2155780</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Alpha subunit variants of the human glycine receptor: primary structures, functional expression and chromosomal localization of the corresponding genes.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Grenningloh G, Schmieden V, Schofield PR, Seeburg PH, Siddique T, Mohandas TK, Becker CM, Betz H.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b0c">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9677400</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The human glycine receptor subunit alpha3. Glra3 gene structure, chromosomal localization, and functional characterization of alternative transcripts.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nikolic Z, Laube B, Weber RG, Lichter P, Kioschis P, Poustka A, Mülhardt C, Becker CM.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de3">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">8717357</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The human glycine receptor beta subunit: primary structure, functional characterisation and chromosomal localisation of the human and murine genes.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Handford CA, Lynch JW, Baker E, Webb GC, Ford JH, Sutherland GR, Schofield PR.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ff0">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">7565620</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Miyake A, Mochizuki S, Takemoto Y, Akuzawa S.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a16">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9950429</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The 5-HT3B subunit is a major determinant of serotonin-receptor function.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Davies PA, Pistis M, Hanna MC, Peters JA, Lambert JJ, Hales TG, Kirkness EF.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e47">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17392525</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Niesler B, Walstab J, Combrink S, Möller D, Kapeller J, Rietdorf J, Bönisch H, Göthert M, Rappold G, Brüss M.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e0e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">16116092</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Atomic force microscopy reveals the stoichiometry and subunit arrangement of 5-HT3 receptors.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Barrera NP, Herbert P, Henderson RM, Martin IL, Edwardson JM.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b69">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18761359</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The 5-HT3 receptor--the relationship between structure and function.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Barnes NM, Hales TG, Lummis SC, Peters JA.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26238288</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ion channels gated by acetylcholine and serotonin: structures, biology, and drug discovery.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wu ZS, Cheng H, Jiang Y, Melcher K, Xu HE.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f5a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1387926</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tyers MB, Freeman AJ.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f47">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">29763014</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ondansetron</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Griddine A, Bush JS.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a05">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">7691500</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Markham A, Sorkin EM.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bed">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">25333367</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ondansetron and probiotics in the management of pediatric acute gastroenteritis in developed countries.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Schnadower D, Finkelstein Y, Freedman SB.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de8">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20844345</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hsu ES.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f62">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">25323946</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Palonosetron for the treatment of chemotherapy-induced nausea and vomiting.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Navari RM.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f1e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">7507039</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lee CR, Plosker GL, McTavish D.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fa5">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12532186</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rabasseda X.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ac9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">25949526</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D).</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Min YW, Rhee PL.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c83">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17652911</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hirata T, Keto Y, Funatsu T, Akuzawa S, Sasamata M.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d37">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">29774051</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lacy BE, Nicandro JP, Chuang E, Earnest DL.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a2b">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11485506</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Camilleri M, Chey WY, Mayer EA, Northcutt AR, Heath A, Dukes GE, McSorley D, Mangel AM.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b1c">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">21180598</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lucak SL.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e32">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">16389408</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cilansetron.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Olden KW, Crowell MD.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de7">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">28291778</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zheng Y, Yu T, Tang Y, Xiong W, Shen X, Jiang L, Lin L.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cba">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22993341</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A randomized controlled non-inferiority study comparing the antiemetic effect between intravenous granisetron and oral azasetron based on estimated 5-HT3 receptor occupancy.</bp:TITLE>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Endo J, Iihara H, Yamada M, Yanase K, Kamiya F, Ito F, Funaguchi N, Ohno Y, Minatoguchi S, Itoh Y.</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>

